市場調查報告書
商品編碼
1567803
2030 年亞太地區中胚層療法市場預測 - 區域分析 - 按產品類型、適應症和最終用戶Asia Pacific Mesotherapy Market Forecast to 2030 - Regional Analysis - by Product Type, Indication, and End Users |
2022年亞太地區中胚層療法市場估值為1.0691億美元,預計2030年將達到2.2442億美元;預計2022年至2030年複合年成長率為9.7%。
技術進步帶來的舒適度、效率和結果的改善推動了亞太地區中胚層療法市場的發展
自動注射設備、奈米技術和無針美塑療法等技術發展改善了治療效果,提高了患者的舒適度,並提高了美塑療法的效率。這些技術的引入徹底改變了中胚層療法產品的交付方式。例如,自動注射設備採用先進技術來精確管理注射深度、速度和體積,確保藥物準確地放置在皮膚中。自動注射設備提高了中胚層療法的均勻性和功效,同時降低了人為錯誤的風險,從而改善了治療結果。同樣,奈米技術使得特定美塑療法配方的開發成為可能,該配方使用奈米尺寸的顆粒來改善活性成分在皮膚上的分佈。例如,脂質體是一種基於脂質的囊泡,可以封裝藥用物質並將其運輸到特定位置,從而提高其吸收和生物利用度。這些改進的遞送技術提供了更高的成分滲透性、更高的治療功效以及活性化合物的持續釋放,從而為患者帶來長期效果。
無針美塑療法採用超音波技術。這種類型的中胚層療法是將藥妝品和注射化合物輸送到皮膚中層(中真皮)的安全方法。利用溫和的低頻電流與超音波結合,將天然精華液透過皮膚表面下的小通道深入細胞層面。抗氧化劑、維生素、胜肽和透明質酸等天然元素有助於使皮膚看起來更健康、更光滑、膚色更年輕。因此,美塑療法技術的進步在推動美塑療法市場的成長方面發揮著重要作用。
亞太地區中胚層療法市場概況
預計2022年至2030年,亞太地區美塑療法市場將以高複合年成長率成長。在中國,中胚層療法在各公立和私立醫院中獲得了巨大的關注。另一方面,隨著醫療保健的持續發展以及人們在此類手術上的支出意願的增加,預計印度市場在未來幾年將加快步伐。同時,隨著美容旅遊業的不斷發展,韓國的中胚層療法市場可能會蓬勃發展。中國擁有亞太地區最大的美塑療法市場。蓬勃發展的美容產業、皮膚病的高發病率、人們對美容手術以增強美學吸引力的意識不斷增強,以及對微創手術(皮膚再生和增強)的需求不斷增加,推動了該國市場的成長。據上海市人民政府稱,中國約有70%的人患有濕疹、帶狀皰疹等皮膚問題。另據報導,濕疹、皮膚搔癢、帶狀皰疹是老年族群中診斷的前三位皮膚病。濕疹和帶狀皰疹可以透過美塑療法治療。
亞太地區中胚層療法市場收入及2030年預測(百萬美元)
亞太地區中胚層療法市場區隔
亞太地區中胚層療法市場按產品類型、適應症、最終用戶和國家分類。
根據產品類型,亞太地區美塑療法市場分為美塑療法解決方案套件、美塑療法設備、美塑療法填充套件、美塑療法化學換膚和抗衰老面膜。中胚層療法解決方案套件細分市場在 2022 年佔據最大的市場佔有率。
從適應症來看,亞太地區中胚層療法市場分為抗衰老和皺紋治療、臉部年輕化、減肥、脫髮、妊娠紋以及痤瘡和疤痕治療。 2022年,抗衰老和皺紋治療設備領域佔據亞太美塑療法市場的最大佔有率。
根據最終用戶,亞太地區美塑療法市場分為皮膚科診所、美容診所、醫院等。 2022年,皮膚科診所佔據亞太美塑療法市場的最大佔有率。
依國家分類,亞太地區美塑療法市場分為中國、日本、印度、韓國、澳洲和亞太其他地區。 2022年,中國在亞太美塑療法市場佔有率中佔據主導地位。
Koru Pharma Co Ltd、Institute BCN Esthetics SL、Mesoskinline ApS、高露潔棕欖 Co、Toskani SL、Mesoestetic E-Commerce SL、Galderma SA、Derm Beauty International Sdn Bhd、Mesotech Srl 和 Ostar Beauty Sci-Tech Co Ltd 等亞太美塑療法市場的領先公司。
The Asia Pacific mesotherapy market was valued at US$ 106.91 million in 2022 and is expected to reach US$ 224.42 million by 2030; it is estimated to register a CAGR of 9.7% from 2022 to 2030.
Improvements in Comfort, Efficiency, and Outcomes with Technological Advancements Boost Asia Pacific Mesotherapy Market
Technological developments such as automated injection devices, nanotechnology, and no-needle mesotherapy have improved treatment outcomes, enhanced patient comfort, and increased efficiency in mesotherapy treatments. The introduction of these technologies has revolutionized the way mesotherapy products are delivered. For instance, automated injection devices use advanced technology to precisely manage the depth, pace, and volume of injections, ensuring that the drugs are accurately placed in the skin. Automated injection devices improve the uniformity and efficacy of mesotherapy treatments, along with lowering the risk of human errors, thereby improving the outcomes. Similarly, nanotechnology has enabled the development of specific mesotherapy formulations that use nano-sized particles to improve active ingredient distribution to the skin. Liposomes, for instance, are lipid-based vesicles that can encapsulate medicinal substances and transport them to specific locations, thereby improving their absorption and bioavailability. These improved delivery technologies provide higher ingredient penetration, increased therapy efficacy, and sustained release of active compounds, resulting in longer-term results in patients.
No-needle mesotherapy treatments use ultrasonic technology. This type of mesotherapy is a safe method of delivering cosmeceutical and injectable compounds into the middle layer (mesodermis) of the skin. Natural serums are carried deep into the cellular level via small channels under the skin surface by utilizing a mild low-frequency current in conjunction with ultrasound. Natural elements such as antioxidants, vitamins, peptides, and hyaluronic acid help make the skin appear healthier, smoother, toned, and youthful. Thus, advancements in mesotherapy technology play a significant role in driving the growth of the mesotherapy market.
Asia Pacific Mesotherapy Market Overview
The Asia Pacific mesotherapy market is expected to grow at a high CAGR from 2022 to 2030. The market in China and Japan is expected to grow at a fast pace due to the increasing popularity of mesotherapy and growing medical tourism. In China, mesotherapy is gaining significant traction in various public and private hospitals. On the other hand, the market in India is expected to pick pace in the coming years with ongoing developments in healthcare and increasing people's willingness to spend on such procedures. Meanwhile, the mesotherapy market in South Korea is likely to flourish with the increasing cosmetic tourism. China holds the largest mesotherapy market in Asia Pacific. The burgeoning aesthetic industry, high prevalence of skin diseases, growing awareness of cosmetic procedures to enhance aesthetic appeal, and increasing demand for minimally invasive procedures (for skin rejuvenation and enhancement) propel the market growth in this country. According to the Shanghai Municipal People's Government, ~70% of people in China suffer from skin problems, such as eczema and shingles. It is also reported that eczema, skin pruritus, and shingles are the top 3 skin diseases diagnosed in the elderly population. Eczema and Shingles can be treated through mesotherapy.
Asia Pacific Mesotherapy Market Revenue and Forecast to 2030 (US$ Million)
Asia Pacific Mesotherapy Market Segmentation
The Asia Pacific mesotherapy market is categorized into product type, indication, end users, and country.
Based on product type, the Asia Pacific mesotherapy market is segmented into mesotherapy solution kits, mesotherapy devices, mesotherapy fillers kits, mesotherapy chemical peels, and anti-ageing masks. The mesotherapy solution kits segment held the largest market share in 2022.
In terms of indication, the Asia Pacific mesotherapy market is segmented into anti-ageing & wrinkle treatment, facial rejuvenation, fat loss, hair loss, stretch marks, and acne & scar treatment. The anti-ageing & wrinkle treatment devices segment held the largest share of Asia Pacific mesotherapy market in 2022.
Based on end users, the Asia Pacific mesotherapy market is categorized into dermatology clinics, cosmetic clinics, hospitals, and others. The dermatology clinics segment held the largest share of Asia Pacific mesotherapy market in 2022.
Based on country, the Asia Pacific mesotherapy market is categorized into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China dominated the Asia Pacific mesotherapy market share in 2022.
Koru Pharma Co Ltd, Institute BCN Esthetics SL, Mesoskinline ApS, Colgate Palmolive Co, Toskani SL, Mesoestetic E-Commerce SL, Galderma SA, Derm Beauty International Sdn Bhd, Mesotech Srl, and Ostar Beauty Sci-Tech Co Ltd are some of the leading companies operating in the Asia Pacific mesotherapy market.